Form 8-K - Current report:
SEC Accession No. 0001493152-24-022732
Filing Date
2024-06-05
Accepted
2024-06-05 16:07:15
Documents
14
Period of Report
2024-06-01
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40135
2 ex16-1.htm EX-16.1 4350
  Complete submission text file 0001493152-24-022732.txt   216531

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE eltp-20240601.xsd EX-101.SCH 3024
4 XBRL LABEL FILE eltp-20240601_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE eltp-20240601_pre.xml EX-101.PRE 22365
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3470
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: NJ | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-15697 | Film No.: 241022044
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)